BRPI0815760A2 - Composição dermatológica injetável para o tratamento de rugas - Google Patents

Composição dermatológica injetável para o tratamento de rugas

Info

Publication number
BRPI0815760A2
BRPI0815760A2 BRPI0815760-0A2A BRPI0815760A BRPI0815760A2 BR PI0815760 A2 BRPI0815760 A2 BR PI0815760A2 BR PI0815760 A BRPI0815760 A BR PI0815760A BR PI0815760 A2 BRPI0815760 A2 BR PI0815760A2
Authority
BR
Brazil
Prior art keywords
dermatological composition
wrinkle treatment
injectable dermatological
injectable
wrinkle
Prior art date
Application number
BRPI0815760-0A2A
Other languages
English (en)
Inventor
Giovanni Cavallo
Maurizio Ceccarelli
Mario Marchetti
Piero Piccioli
Original Assignee
Italfarmacia S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmacia S R L filed Critical Italfarmacia S R L
Publication of BRPI0815760A2 publication Critical patent/BRPI0815760A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/447—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
BRPI0815760-0A2A 2007-08-22 2008-08-22 Composição dermatológica injetável para o tratamento de rugas BRPI0815760A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07016441A EP2033689A1 (en) 2007-08-22 2007-08-22 Injectable dermatological composition for treatment of the wrinkles
PCT/EP2008/006909 WO2009024350A2 (en) 2007-08-22 2008-08-22 Injectable dermatological composition for treatment of wrinkles

Publications (1)

Publication Number Publication Date
BRPI0815760A2 true BRPI0815760A2 (pt) 2014-09-30

Family

ID=38885297

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0815760-0A2A BRPI0815760A2 (pt) 2007-08-22 2008-08-22 Composição dermatológica injetável para o tratamento de rugas

Country Status (4)

Country Link
EP (2) EP2033689A1 (pt)
BR (1) BRPI0815760A2 (pt)
EA (1) EA021963B1 (pt)
WO (1) WO2009024350A2 (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2829971T3 (es) 2008-09-02 2021-06-02 Tautona Group Lp Hilos de ácido hialurónico y/o derivados de los mismos, métodos para fabricar los mismos y usos de los mismos
JP5795960B2 (ja) * 2009-09-14 2015-10-14 株式会社 資生堂 紫外線障害軽減組成物
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
DK2550027T4 (da) 2010-03-22 2019-05-13 Allergan Inc Tværbundne polysaccharid- og protein-polysaccharid-hydrogeler til blødvævsforøgelse
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
US8524662B2 (en) 2010-12-28 2013-09-03 Depuy Mitek, Llc Compositions and methods for treating joints
EP2484387A1 (en) 2011-02-03 2012-08-08 Q-Med AB Hyaluronic acid composition
EP3536307B1 (en) 2011-06-03 2021-10-20 ALLERGAN Industrie, SAS Dermal filler compositions including antioxidants
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US8623839B2 (en) 2011-06-30 2014-01-07 Depuy Mitek, Llc Compositions and methods for stabilized polysaccharide formulations
JP2013014555A (ja) * 2011-07-06 2013-01-24 Shiseido Co Ltd コラーゲン産生の促進方法
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
FR2984733B1 (fr) * 2011-12-22 2016-09-30 Oreal Association d'un agent nucleophile et d'un agent azote ou phosphore de pka superieur a 11 pour la peau glyquee
WO2014041528A2 (en) * 2012-09-14 2014-03-20 Martin Roslain Margaret A composition
ES2678875T3 (es) * 2013-03-04 2018-08-20 DERMELLE, LLC d/b/a ETERNOGEN, LLC Composición de colágeno polimerizable in situ inyectable
CN106659663A (zh) 2014-06-30 2017-05-10 纽璀克斯技术公司 控制影响角化细胞和/或成纤维细胞和真皮的皮肤失调和皮肤老化的组合产品和美容组合物
FR3022779B1 (fr) * 2014-06-30 2018-03-30 Nutricos Technologies Produits de combinaison et compositions cosmetiques pour lutter contre les desordres de la peau et son vieillissement affectant les keratinocytes
ES2761558T3 (es) 2014-09-30 2020-05-20 Allergan Ind Sas Composiciones de hidrogel estables que incluyen aditivos
WO2016088078A1 (en) * 2014-12-04 2016-06-09 Professional Dietetics S.P.A. Aminoacid-based composition for fibroelastin recovery in dermal connective tissues
US9682099B2 (en) 2015-01-20 2017-06-20 DePuy Synthes Products, Inc. Compositions and methods for treating joints
GB201703850D0 (en) * 2017-03-10 2017-04-26 Givaudan Sa Improvements in or relating to organic compounds
FR3080765B1 (fr) * 2018-05-04 2020-10-30 Naos Inst Of Life Science Composition comprenant de l'acide alpha-lipoique ou l'un de ses sels, un derive de vitamine c et de l'acide hyaluronique et son utilisation
EP3788137A1 (fr) * 2018-05-04 2021-03-10 NAOS Institute of Life Science Composition comprenant de l'acide alpha-lipoique ou l'un de ses sels, un derive de vitamine c et de l'acide hyaluronique et son utilisation
WO2021018377A1 (en) * 2019-07-29 2021-02-04 Giuliani S.P.A. Cosmetic composition with combined filler and skin regenerative effect
US20230148647A1 (en) * 2020-09-02 2023-05-18 Elastic Lab Inc. Composition for promoting biosynthesis of elastin and collagen in connective tissue
KR102226810B1 (ko) 2020-09-02 2021-03-15 주식회사 엘라스틱랩 연결 조직 중 엘라스틴 및 콜라겐 생합성 증진용 조성물
DE102022113526A1 (de) * 2022-05-30 2023-11-30 Louna Aesthetics SAS Verfahren zur Herstellung einer Zusammensetzung, Zusammensetzung und Verwendung der Zusammensetzung

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA939265A (en) * 1967-11-18 1974-01-01 Yoshitaka Ikezuki Injectable compositions for alleviating the pain incurred from administrations of injections
EP0505108B1 (en) * 1991-03-21 1995-10-18 The Procter & Gamble Company Compositions for regulating skin wrinkles comprising an Arg-Ser-Arg-Lys based peptide
US5198465A (en) * 1991-06-19 1993-03-30 Dioguardi Francesco S Compositions based on amino acids for preventing and treating precursor deficiencies in the synthesis of collagen
WO1994005279A1 (en) * 1992-09-04 1994-03-17 Aws Shakir Mustafa Salim Dermatological treatment compositions containing dimethylsulphone and a sulfur containing amino acid
FR2704754B1 (fr) * 1993-05-07 1995-06-30 Oreal Utilisation d'un alkyle ester de glutathion dans une composition cosmetique ou dermatologique destinee au traitement par voie topique du vieillissement cutane.
EP1120407B1 (en) * 1998-10-09 2013-02-20 Ajinomoto Co., Inc. Cystine derivatives
IT1304191B1 (it) * 1998-12-18 2001-03-08 Solartium Establishment Composizione farmaceutica a base di prolina, glicina e lisina utilenella terapia odontoiatrica sia sotto forma iniettabile che in
IT1318556B1 (it) * 2000-06-07 2003-08-27 Solartium Establishment Composizione farmaceutica a base di prolina, glicina e lisina utilenella terapia per la cicatrizzazione delle ferite e delle lesioni
US6955816B2 (en) * 2001-11-16 2005-10-18 Klysz Beatrice M Anti-aging skin care composition and uses thereof
US20040101959A1 (en) * 2002-11-21 2004-05-27 Olga Marko Treatment of tissue with undifferentiated mesenchymal cells
BRPI0417884A (pt) * 2003-12-30 2007-04-27 Med Care S R L composições compreendendo vitaminas e/ou derivados das mesmas, estabilizados com extrato de olea europea e/ou polìmeros de ioneno
JP4815752B2 (ja) * 2004-04-01 2011-11-16 味の素株式会社 アミノ酸含有飲食品
WO2006020994A2 (en) * 2004-08-13 2006-02-23 Angiotech International Ag Compositions and methods using hyaluronic acid and hyluronidase inhibitors
US20060275909A1 (en) * 2005-05-26 2006-12-07 Spitzer Alan R Nutrition formulations and methods of providing nutrition formulations
US20070077292A1 (en) * 2005-10-03 2007-04-05 Pinsky Mark A Compositions and methods for improved skin care
US9265792B2 (en) * 2005-11-16 2016-02-23 Patricia A. Riley Integument cell regeneration formulation

Also Published As

Publication number Publication date
EP2203222A2 (en) 2010-07-07
WO2009024350A2 (en) 2009-02-26
WO2009024350A3 (en) 2009-07-16
EA021963B1 (ru) 2015-10-30
EP2033689A1 (en) 2009-03-11
EP2203222B1 (en) 2021-08-04
EA201000078A1 (ru) 2010-10-29
WO2009024350A8 (en) 2011-05-12

Similar Documents

Publication Publication Date Title
BRPI0815760A2 (pt) Composição dermatológica injetável para o tratamento de rugas
BRPI0812746A2 (pt) Aplicador para uma composição de tratamento capilar
BRPI0910282A2 (pt) Composto oxadiazo-antraceno para o tratamento de diabetes
BRPI0813352A2 (pt) Composições de fragmento de tecido para o tratamento de incontinência
BRPI0813725A2 (pt) Métodos e composições para tratamento de doenças
BRPI0906746A2 (pt) Aparelho para tratamento de doença de refluxo gastresofágico
BRPI0917751A2 (pt) parafuso ósseo
BRPI0919238A2 (pt) métodos e composições para o tratamento de câncer
BR112012000502A2 (pt) terapia de combinação para o tratamento de diabetes
BRPI0813670A2 (pt) Compostos para tratamento
BRPI0909164A2 (pt) método e composições para o tratamento de câncer
BRPI1006024A2 (pt) composição cosmética emulsificada
BRPI0914410A2 (pt) composição de polidesoxirribonucleotídeo injetável para o tratamento de doenças osteoarticulares.
BRPI1006145A2 (pt) "composição e método para tratamento de diabetes".
BRPI0922884A2 (pt) compostos para tratamento de câncer
BRPI1010874A2 (pt) composição para o tratamento de câncer de próstata
BRPI0915439A2 (pt) composição tópica para o tratamento de ceratose actínica
BRPI0922367A2 (pt) enzastaurin para o tratamento de câncer
BRPI0818170A2 (pt) 5-cianotienopiridinas para o tratamento de tumores.
BRPI0920728A2 (pt) Composição estabilizada para tratamento de psoríase
BRPI0810207A2 (pt) Métodos e composições para o tratamento de câncer
HK1154797A1 (en) Composition for treating disease
BRPI0917552A2 (pt) kit para o tratamento de onicomicose
BRPI0907723A2 (pt) Métodos e composições para o tratamento de doença respiratória
BRPI0810762A2 (pt) Composição para tratamento da água

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements